Providing Appropriate Medical Care for IBD Patients Grant

Providing Appropriate Medical Care for IBD Patients Grant

Status: ACTIVE
Funder: Pfizer, Inc.
Amount: Up to ¥2,000,000
Last Updated: April 02, 2026

Summary

The Japanese Society for Inflammatory Bowel Disease (JSIBD) and Pfizer are seeking applications for a Quality Improvement (QI) grant program aimed at enhancing medical care for patients with inflammatory bowel disease (IBD). This initiative focuses on improving healthcare professionals' skills through clinical practice and education, fostering networks, and implementing projects that promote appropriate treatment for IBD, ultimately aiming for better patient outcomes.

Overview

Background Japanese Society for Inflammatory Bowel Disease (JSIBD) and Pfizer invite applications for this Quality Improvement (QI) grant program targeting initiatives for healthcare professionals to provide appropriate medical care for patients with inflammatory bowel disease (IBD). The program will help build systems allowing appropriate clinical practice/education and establish networks by aiming to improve the skills of healthcare professionals engaged in IBD treatment through implementation of the selected projects.

Eligibility

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.